We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Inflammatory Marker Levels Established In Specific Obese Adolescents

By LabMedica International staff writers
Posted on 21 Mar 2012
Print article
Levels of inflammatory biomarkers in the blood have been measured in obese adolescents who are glucose intolerant and possibly prediabetic.

Increased levels of systemic inflammatory markers, such as C-reactive protein (CRP), the cytokine interleukin-6 (IL-6) and elevated pteridine derivatives as well as specific enzyme levels may be influenced by glucose intolerance.

At the Ege University, (Izmir, Turkey) scientists performed oral glucose tolerance tests (OGTT) on 45 pubertal obese children, 23 girls and 22 boys with a mean age of 13.52 years. Biochemical analyses were performed on the sample collection day, that included glucose, insulin, glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), apolipoprotein AI (Apo A), apolipoprotein B100 (Apo B), CRP, IL-6, neopterin levels, complete blood count and chitotriosidase activities. Serum chitotriosidase activity was measured by a fluorescence method and fasting serum concentrations of IL-6 and neopterin were determined by the use of commercial enzyme-linked immunosorbent assays (ELISA).

In 21 children, normal glucose tolerance (NGT) was observed being defined as fasting glucose levels of less than 5.6 mmol/L and two hour glucose levels of less than 7.8 mmol/L. Impaired glucose tolerance (IGT) was found in 24 children where after the OGTT, the two hour glucose levels were between 7.8 and 11.1 mmol/L. The IL-6 and CRP levels were similar in the two groups. There was no significant difference in the lipid profiles or serum neopterin levels between the groups. However, the chitotriosidase activity was significantly higher in the IGT group at 124.33 ± 51.97 μmol/L/hour than the NGT group where the mean activity was 84.50 ± 53.99 μmol/L/hour. The chitotriosidase activity was measured on the F-2500 fluorometer (Hitachi Ltd., Tokyo, Japan). The fasting serum concentrations of IL-6 was determined by the ELISA kit from DIA Source (Louvain-La-Neuve, Belgium) and neopterin levels with an ELISA from DRG Instruments, (Marburg, Germany).

Activated macrophages secrete several proteins, like neopterin and chitotriosidase, which could influence the atherosclerotic process, leading to a local inflammation in the vessel wall. The authors concluded that the results of their study show that serum chitotriosidase activity is increased in obese adolescents with impaired glucose tolerance. Impaired glucose tolerant state is an important period in which atherosclerotic lesions start to emerge. The results demonstrate that the existence of glucose intolerance may aggravate the local inflammation, which mainly occurs in the vascular bed in obese children. The study was published in the March 2012 issue of the journal Clinical Biochemistry.

Related Links:
Ege University
Hitachi Ltd.
DIA Source



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.